Abiopharma

News list

📋 JOHN HENDERSON (Director) plans to sell 20K shares of CYTOKINETICS, INCORPORATED (at $66.05 each, total $1.3M) Filed: May 05, 2026 | ID: 004061

Full text

News bot May 5, 2026, 8:32 p.m.
📋 Form 144 Filing: JOHN HENDERSON

Company: CYTOKINETICS, INCORPORATED

Filing Date: 2026-05-05

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 20,000
- Price per Share: $66.05
- Total Value: $1,321,000.00
- Planned Sale Date: 2026-05-05
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-50633
- Issuer Contact Phone: 6506243000
- Issuer Address: 350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 123162807.0
- Number of Securities to be Sold: 1
- Signature: /s/ John Henderson
- Plan Adoption Dates: 2025-09-02